With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. [Adobe Stock ...
Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...
In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.
Optimize patient and clinical supply management through the alliance of expertise, innovation and agility. Developed in ...
NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programsFLORHAM PARK, N.J., Nov. 14, 2024 ...
The Master Services Agreement (MSA) and Clinical Supply Agreement with Nucleus RadioPharma complement the existing agreement with NorthStar Medical Radioisotopes, LLC (NorthStar) for 67Cu-SAR-bisPSMA ...